Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency
- 23 February 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (4) , 967-971
- https://doi.org/10.1016/j.bmcl.2003.12.032
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrateNucleic Acids Research, 2004
- Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivativesBioorganic & Medicinal Chemistry Letters, 2003
- Identification of N,N-Disubstituted Phenylalanines as a Novel Class of Inhibitors of Hepatitis C NS5B PolymeraseJournal of Medicinal Chemistry, 2003
- Treatment of chronic hepatitis C: A systematic reviewHepatology, 2002
- Optimal therapy of hepatitis CHepatology, 2002
- Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA PolymeraseJournal of Biological Chemistry, 2002
- Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCVCurrent Medicinal Chemistry - Anti-Infective Agents, 2002
- Epidemiology of Hepatitis C: Geographic Differences and Temporal TrendsSeminars in Liver Disease, 2000
- Hepatitis CThe Lancet, 1998
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989